Tonsil cancer is a type of throat cancer that develops in the palatine tonsils, the two oval-shaped pads of tissue at the back of your mouth. Most tonsil cancers are squamous cell carcinomas, meaning they start in the thin, flat cells lining the tonsil surface or, more commonly now, in the deeper lymphoid tissue of the tonsil crypts. It falls under the broader category of oropharyngeal cancer, and its behavior and outlook depend heavily on whether the human papillomavirus (HPV) is involved.
Why HPV Changed Everything About This Cancer
HPV is thought to cause 60% to 70% of oropharyngeal cancers in the United States, and the tonsils are the most common site for these HPV-driven cancers. This has fundamentally reshaped how doctors classify and treat the disease. The World Health Organization now divides tonsil squamous cell carcinoma into two distinct groups: HPV-positive and HPV-negative.
HPV-positive tonsil cancers grow from the deep lymphoid tissue inside the tonsil crypts. They tend to appear in younger, otherwise healthy people and carry a significantly better prognosis. HPV-negative tonsil cancers develop from the surface lining of the tonsil and are more strongly tied to tobacco and alcohol use. These two types are now staged differently, with HPV-positive cancers having their own separate staging system because their outcomes are so much more favorable.
Risk Factors
The two main drivers of tonsil cancer are HPV infection and the combination of tobacco and alcohol use. For HPV-negative cancers, smoking and drinking together create a risk that isn’t just additive. The effect is multiplicative, meaning the combined risk is far greater than you’d get by adding the individual risks together. Some research has found that heavy drinkers who also smoke heavily face up to 300 times the risk of oral and pharyngeal cancers compared to people who do neither.
HPV-positive tonsil cancer follows a different pattern. It’s linked to oral HPV infection, which is sexually transmitted. The typical patient is younger, may have never smoked, and often has no traditional risk factors. Men are diagnosed with HPV-related oropharyngeal cancer at significantly higher rates than women.
Symptoms to Recognize
The most common symptom is a sore throat that doesn’t go away. Unlike a sore throat from a cold or infection, this one persists for weeks and doesn’t respond to antibiotics or time. Another hallmark sign is one tonsil that looks noticeably larger than the other.
Other symptoms include:
- Ear pain on one side, often without any ear infection present
- Difficulty swallowing, speaking, or chewing
- Blood in your saliva
- Persistent bad breath that doesn’t improve with oral hygiene
- A lump in the neck from swollen lymph nodes
- Sores in the back of the mouth that won’t heal
Many people with HPV-positive tonsil cancer first notice a painless lump in their neck before they have any throat symptoms at all. This happens because the cancer has already spread to a nearby lymph node, even while the primary tumor on the tonsil remains small.
How Tonsil Cancer Is Diagnosed
A doctor typically starts with a physical exam of the throat and neck. They may use a small mirror or a thin camera threaded through the nose to get a clear view of the tonsils and surrounding tissue. They’ll also feel your neck for swollen lymph nodes.
If something looks suspicious, a biopsy confirms the diagnosis. This involves removing a small piece of tonsil tissue, either by cutting a sample directly from the tonsil or by using a needle to draw cells from a swollen lymph node in the neck. The tissue sample is tested in a lab for cancer cells and for HPV status, which is determined through a protein marker called p16. Whether the cancer is p16-positive or p16-negative determines which staging system applies and shapes the entire treatment plan.
Imaging tests help determine how far the cancer has spread. CT scans and MRIs show the size and location of the tumor, while PET scans highlight areas of high metabolic activity throughout the body, which helps detect cancer that may have spread beyond the throat.
Treatment Options
Treatment depends on the cancer’s stage, HPV status, and location. The main approaches are surgery, radiation therapy, and chemotherapy, often used in combination.
For early-stage tonsil cancer, surgery may be performed through the mouth using robotic instruments, avoiding the need for large external incisions. This approach allows for faster recovery and less disruption to swallowing and speech. Radiation therapy, often delivered using precision techniques that focus the beam tightly on the tumor, is another primary option for early-stage disease.
More advanced cancers typically require a combination of radiation and chemotherapy given at the same time. Because HPV-positive cancers respond so well to treatment, researchers are actively studying whether some patients can receive lower-intensity therapy to reduce side effects without compromising outcomes.
Side Effects of Treatment
Radiation to the head and neck can damage the salivary glands, leading to chronic dry mouth. This isn’t just uncomfortable. It increases the risk of tooth decay and mouth infections long after treatment ends. Sipping water frequently, sucking on ice chips or sugar-free candy, and using saliva substitutes all help manage it. Some patients find acupuncture provides relief as well.
Difficulty swallowing is another common side effect, sometimes lasting months or longer after treatment. Eating soft, moist foods and using sauces or gravies to soften meals makes swallowing easier during recovery. Some patients work with a speech and swallowing therapist to rebuild function. Changes in taste, sore throat, and fatigue are also common during and after radiation.
Survival Rates and Outlook
Survival rates for oral and pharyngeal cancers vary considerably by stage. When the cancer is still confined to the tonsil, the five-year relative survival rate is about 89%. Once it has spread to nearby lymph nodes, that drops to roughly 70%. For cancer that has spread to distant parts of the body, the five-year survival rate is around 36%.
These numbers combine HPV-positive and HPV-negative cases. HPV-positive tonsil cancers have a substantially better prognosis. Patients with HPV-positive disease who receive standard treatment have cure rates well above those averages, even when the cancer has spread to neck lymph nodes, which is actually how most HPV-positive cases are first discovered.
Prevention Through HPV Vaccination
The HPV vaccine offers strong protection against the strains of HPV responsible for most tonsil cancers. A meta-analysis found that vaccinated individuals had an 80% lower chance of carrying oral HPV16 compared to unvaccinated people. One large study of over 600,000 men found that among those who developed oropharyngeal cancer, virtually all were unvaccinated, with unvaccinated men facing a nearly 24-fold higher relative risk.
The vaccine is most effective when given before exposure to the virus, which is why it’s recommended for preteens. But studies show it also produces detectable oral antibodies in men vaccinated as late as their mid-40s, with over 93% developing antibodies to HPV16 within seven months of vaccination. For those outside the vaccine window, avoiding tobacco and limiting alcohol remain the most impactful ways to reduce risk.